Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 296.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.336%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 296.50
MSLH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Rights Issue

16 Jun 2009 07:00

RNS Number : 9300T
Marshalls PLC
16 June 2009
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA, MALTA, NEW ZEALAND OR ANY OTHER JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL.

Marshalls plc

16 June 2009

Result of Rights Issue

Marshalls plc ("Marshalls" or "the Company") announces that it has received valid acceptances in respect of 50,885,764 New Ordinary Shares, representing approximately 90.4% of the total number of New Ordinary Shares offered to Qualifying Shareholders, pursuant to the Rights Issue announced by the Company on 13 May 2009.

It is expected that the New Ordinary Shares in uncertificated form will be credited to CREST accounts on 16 June 2009 and that definitive share certificates in respect of New Ordinary Shares in certificated form will be dispatched to Shareholders by no later than 23 June 2009. It is expected that the New Ordinary Shares will commence trading fully paid on London Stock Exchange plc's main market for listed securities on 16 June 2009.

As disclosed in Part III of the prospectus sent to shareholders dated 13 May 2009 ("Prospectus"), Citi and Numis will endeavour to procure subscribers for the balance of 5,386,737 New Ordinary Shares not validly taken up under the Rights Issue, on and subject to the terms and conditions agreed with the Company under the Underwriting Agreement. A further announcement as to the number of New Ordinary Shares for which subscribers have been so procured will be made in due course.

Unless otherwise defined in this announcement, capitalised terms shall have the meaning given to them in the Prospectus.

Contacts

 

For further information please contact:

Marshalls plc Tel: +44(0) 1484 438 900

Graham Holden, Chief Executive

Ian Burrell, Finance Director

Brunswick Group LLP  Tel: +44(0) 207 404 5959

Jon Coles

Kate Miller

This announcement does not contain or constitute an offer of, or the solicitation of an offer to buy or subscribe for, securities to any person in Australia, Canada, Japan, South Africa, Malta, New Zealand or the United States or in any jurisdiction to whom or in which such offer or solicitation is unlawful. The securities referred to herein may not be offered or sold in the United States absent registration under the United States Securities Act of 1933, as amended ("Securities Act") or another exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Subject to certain exceptions, the securities referred to herein may not be offered or sold in Australia, Canada, Japan, South Africa, Malta or New Zealand or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada, Japan, South Africa, Malta or New Zealand. The offer and sale of the securities referred to herein has not been and will not be registered under the Securities Act or under the applicable securities laws of Australia, Canada, Japan, South Africa, Malta or New Zealand. There will be no public offer of the securities in the United States. The availability of the Rights Issue to persons not resident in the United Kingdom may be affected by the laws of the relevant jurisdictions. Such persons should inform themselves about and observe any application requirements.

Citigroup Global Markets Limited and Citigroup Global Markets U.K. Equity Limited (each and together, "Citi") and Numis Securities Limited ("Numis") are each regulated and authorised by the Financial Services Authority in the United Kingdom. Citi and Numis are each acting exclusively for the Company and no one else as Joint Bookrunner in connection with the Rights Issue and the Admission of the New Ordinary Shares and will not regard any other person (whether or not a recipient of this announcement) as a client in relation to the Rights Issue and the Admission of the New Ordinary Shares and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Citi or Numis or for providing advice in relation to the Rights Issue, the Admission of the New Ordinary Shares, the contents of this announcement or any matters or arrangements referred to herein or therein.

This announcement is for information only and does not constitute or form part of any offer or invitation to issue, acquire or dispose of any securities or investment advice in any jurisdiction.

This announcement is not a prospectus and investors should not subscribe for or purchase any New Ordinary Shares referred to in this announcement in connection with the Rights Issue except on the basis of the information contained in the Prospectus.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROIEELFFKQBZBBK
Date   Source Headline
13th May 20203:38 pmRNSResult of AGM
13th May 20207:00 amRNSTrading Statement
5th May 20202:13 pmRNSDirector/PDMR Shareholding
5th May 20202:09 pmRNSDirector/PDMR Shareholding
27th Apr 20201:29 pmRNSArticles of Association
23rd Apr 20205:07 pmRNSHolding(s) in Company
14th Apr 20207:00 amRNSCOVID-19 Update
8th Apr 20204:47 pmRNSAnnual Financial Report
7th Apr 20201:14 pmRNSDirector/PDMR Shareholding
7th Apr 20201:12 pmRNSDirector/PDMR Shareholding
27th Mar 20207:00 amRNSCOVID-19 update
19th Mar 20201:27 pmRNSDirector Declaration
13th Mar 202011:11 amRNSDirector/PDMR Shareholding
12th Mar 20202:37 pmRNSDirector/PDMR Shareholding
12th Mar 20202:34 pmRNSDirector/PDMR Shareholding
12th Mar 20202:32 pmRNSDirector/PDMR Shareholding
12th Mar 20207:00 amRNSFinal Results
4th Mar 20202:54 pmRNSDirector/PDMR Shareholding
4th Mar 20202:52 pmRNSDirector/PDMR Shareholding
11th Feb 202010:28 amRNSHolding(s) in Company
4th Feb 202012:12 pmRNSDirector/PDMR Shareholding
4th Feb 202012:11 pmRNSDirector/PDMR Shareholding
27th Jan 202011:09 amRNSHolding(s) in Company
21st Jan 20209:27 amRNSDirector/PDMR Shareholding
16th Jan 20207:00 amRNSTrading Statement
9th Jan 20203:35 pmRNSHolding(s) in Company
6th Jan 20205:08 pmRNSDirector/PDMR Shareholding
6th Jan 20205:07 pmRNSDirector/PDMR Shareholding
3rd Jan 202010:44 amRNSDirector Declaration
24th Dec 201910:31 amRNSHolding(s) in Company
4th Dec 20194:29 pmRNSDirector/PDMR Shareholding
4th Dec 20194:27 pmRNSDirector/PDMR Shareholding
15th Nov 20194:09 pmRNSHolding(s) in Company
14th Nov 20194:25 pmRNSHolding(s) in Company
4th Nov 20193:35 pmRNSDirector/PDMR Shareholding
4th Nov 20193:29 pmRNSDirector/PDMR Shareholding
23rd Oct 20192:06 pmRNSHolding(s) in Company
17th Oct 20193:45 pmRNSHolding(s) in Company
16th Oct 20195:10 pmRNSHolding(s) in Company
7th Oct 201911:15 amRNSDirector/PDMR Shareholding
7th Oct 201911:09 amRNSDirector/PDMR Shareholding
1st Oct 201910:00 amRNSDirectorate Change
3rd Sep 201912:37 pmRNSDirector/PDMR Shareholding
3rd Sep 201912:35 pmRNSDirector/PDMR Shareholding
23rd Aug 201912:12 pmRNSDirector/PDMR Shareholding
15th Aug 20197:00 amRNSHalf-year Report
7th Aug 201911:38 amRNSDirector/PDMR Shareholding
7th Aug 201911:35 amRNSDirector/PDMR Shareholding
3rd Jul 20194:44 pmRNSDirector/PDMR Shareholding
3rd Jul 20194:42 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.